Site içinde arama yapın

JamesWilson bir ses eklendi Other
2026-10-23 19:43:53 - Translate -

Ionis (IONS) partner Roche shows sefaxersen cut IgA nephropathy proteinuria 43.1% in Phase 3
Roche gave the first effect size from its IMAgINATION kidney trial at ASN Kidney Week, a clearer read for Ionis Pharmaceuticals Inc. (IONS) on a partnered drug that carries milestones and royalties. Sefaxersen cut proteinuria by 43.1% against placebo at 37 weeks in a Phase 3 trial in IgA nephropathy, according to data Ionis Pharmaceuticals Inc. (IONS) released on October 23. Roche Holding AG,...

0 Yorumlar 0 hisse senetleri 41 Views 0 önizleme

Please log in to like, share and comment!
JasonWilliams bir ses eklendi Other
2026-10-23 15:43:10 - Translate -

Rithm Capital (RITM) distributable earnings slip to $0.55 a share as Newrez lending volume falls 19%
Rithm Capital Corp. (RITM) posted much higher GAAP profit on a swing in mortgage servicing values, but its non-GAAP earnings measure fell as funded mortgage volume dropped from the second quarter. Newrez funded $12.9 billion of mortgages in the third quarter, 19% less than in the second quarter and 21% less than a year earlier. Rithm Capital Corp. (RITM) disclosed the figure in its results for...

0 Yorumlar 0 hisse senetleri 9 Views 0 önizleme

Please log in to like, share and comment!